explore -WSS

explore

author：hotspot 2025-09-30 21:57:18 - browse：66

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Families look for replacement for GSK asthma drug Flovent

WSS

For AI in health care standards, federal regulators join with industry group

Fetal cell organoids grown from amniotic fluid, study finds

State of the Union pitch: Bigger Medicare drug price negotiations

As JPM 2024 winds down, some health tech firms project optimism

Longer MASH drug regimen improved liver, Akero study finds

Medicare drug price negotiation continues, as pharma counteroffers

leisure time

explore

focus

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: BridgeBio, Akero, and human embryo models

Jerome Adams on the need for new antivirals for Covid

HHS names first

Cancer drug shortages should be causing more outrage

Streamlined flu vaccines recommended by FDA advisory panel

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

$1 billion proposal to grow Boston, Massachusetts biotech

explore

Fetal cell organoids grown from amniotic fluid, study finds

The nurse manager staffing crisis is hurting patients

The public health thinking behind the CDC’s new Covid guidance

Longer MASH drug regimen improved liver, Akero study finds

JPM 2024: Verve Therapeutics looks to mainstream genome editing

$1 billion proposal to grow Boston, Massachusetts biotech

explore

Wikipedia

hotspot

leisure time